Catalent Debuts AI Tool for Quality Management

Editor’s Take: AI’s value is less about replacing human expertise and more about supporting better decision-making, reducing delays, and strengthening compliance in highly regulated manufacturing environments.

Catalent Inc., a global contract development and manufacturing organization (CDMO), has launched Qai, an enterprise AI tool designed to elevate the best quality management systems and processes across Catalent’s network.

According to Catalent, Qai, an AI-enabled solution, strengthens quality management system processes (such as deviations and complaints) by harnessing Catalent’s enterprise data to accelerate analysis, root cause identification, and corrective and preventive action development, while improving consistency and speed. Qai represents the first enterprise AI solution launched at Catalent.

“The launch of Qai represents an important milestone in how Catalent is applying advanced technologies, including AI, across our operations to improve consistency, accelerate insight and enable better decision-making,” said Charlie Lickfold, Chief Technology Officer, Catalent. “Innovative AI solutions like Qai strengthen the quality of our operations and better support the teams delivering critical therapies to patients around the world.”

Qai integrates intelligent, AI-driven insights directly into existing quality workflows, enabling faster and more consistent decision-making. The platform was built with the support of Microsoft using Microsoft AI technologies powered by Azure, including Foundry, with supporting data and analytics capabilities from Fabric. Qai improves root cause analysis to reduce repeat deviations, accelerates high-quality reporting, and minimizes documentation delays, supporting compliance while helping teams focus on delivering greater value to customers and the patients they serve.

“Qai reflects what we see as an important application of AI in life sciences: enhancing already robust data analytics and governance to deliver meaningful patient impact,” said Todd Mersch, General Manager, U.S. Life Sciences and MedTech, Microsoft. “By strengthening oversight and consistency across manufacturing processes, Qai supports Catalent’s commitment to delivering for customers and the patients they serve, helping to transform lives.”

More Catalent News

Catalent recently unveiled a new brand identity.